1.4M XNAS Volume
XNAS 21 Apr, 2025 4:02 PM (EDT)
Board Meeting
The next board meeting for Twist Bioscience Corp is on 02 May 2025 for the purpose of Twist Bioscience Corp Second Quarter Earnings Results for 2025
See details
Twist Bioscience Corp Key Metrics
Select
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Check Before You Buy
VIEW FULL CHECKLISTMedium rank
8Positive13Negative
38.1% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
Twist Bioscience Corp Stock Price Analysis
Day Price Range | 34.6 (LTP) 33.736.5 LowHigh |
Week Price Range | 34.6 (LTP) 33.740.8 LowHigh |
Month Price Range | 34.6 (LTP) 33.245.2 LowHigh |
52 Week Price Range | 34.6 (LTP) 2860.9 LowHigh |
Twist Bioscience Corp Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
Twist Bioscience Corp's Revenue was higher than average estimate 3 times in past 3 years
EPS forecast
Current EPS
Avg. Estimate
Hit
EPS is expected to grow by 41.7% in FY25
Consensus Recommendation
12 ANALYST Recommendations
BUY
The consensus recommendation from 12 analysts for Twist Bioscience Corp is BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Twist Bioscience Corp Stock Analysis
Twist Bioscience Corp stock analysis with key metrics, changes, and trends.
| Twist Bioscience Corp Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
|---|---|---|---|---|---|
| Annual Revenue | $312.97 M | 27.69% | positive |
| |
| Annual Net Profit | $208.73 M | 2.01% | negative |
| |
| Price to Earning Ratio | -10.45 | - | negative |
| |
| Stock Price | $34.56 | 23.65% | positive |
| |
| Quarterly Revenue | $88.71 M | 24.08% | positive |
| |
| Quarterly Net profit | $31.59 M | 26.54% | positive |
| |
| Debt to Equity Ratio | 0.18 | - | positive |
| |
| Return on Equity(ROE) | -38.08 % | -38.08% | negative |
| |
| Mutual Fund Holding | 97.27 % | 2.75% | positive |
| |
| Promoter Share Holding | 3.59 % | -0.02% | negative |
| |
| Interest Coverage Ratio | -7177.14 | - | negative |
| |
| Institutional Holding | 113.94 % | 0.06% | positive |
| |
Loading data..
Twist Bioscience Corp - Company Profile
What does Twist Bioscience Corp do?
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Twist Bioscience Corp Management structure
All Gross Remunerations are in USD